Trending...
- PBK Miner completes $80 million Series B financing to support AI cloud mining and increase user investment return by 25%
- Pikmykid Launches $100,000 School Safety Grant Giveaway to Support K–12 Schools Across the U.S
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Sparking Disruptive Innovation in Web3
NEW YORK, May 14, 2025 ~ The Conference Forum has recently announced the highly anticipated Partnerships with Sites Summit, set to take place on September 15, 2025 at the Loews Philadelphia Hotel in Philadelphia, PA. This summit aims to bring together key players in the clinical research industry, including sites, pharmaceutical companies, and contract research organizations (CROs), to address the pressing need for sustainable partnerships that can drive greater patient access and enrollment in clinical trials.
Valerie Bowling, Executive Director of Conference Forum, emphasized the urgency of this summit by stating that "the time is now" for sites to face the increasing burden of complex protocols and high demands for trials. The Partnerships with Sites Summit will provide essential insights and strategies for sites to rebuild and reorient their ecosystem towards success in patient enrollment.
The summit boasts a diverse representation of stakeholders who will engage in frank discussions on how to build an infrastructure that supports site success in patient recruitment and retention. Along with sites and CROs, leading pharmaceutical companies such as Merck, Biogen, Boehringer Ingelheim, Eli Lilly & Co, and Endo will also be presenting at the summit.
More on The PennZone
Confirmed members of the speaking faculty include senior leadership from prominent organizations such as the Society of Clinical Research Sites, The Site Council, the Association for MultiSite Research Corp, and Tufts Center for the Study of Drug Development. They will cover a range of topics including key trends impacting the site ecosystem, collaborations between site networks and bridging technology gaps for more efficient clinical trial operations.
Some of the key topics that will be addressed at this summit include building systems and relationships focused on enrollment goals, addressing site burden through operational efficiency, establishing sustainable partnership infrastructure between sites, pharma and CROs, rebuilding trust through proactive involvement of sites in protocol feasibility assessment, bridging technology gaps to reduce burden on sites and key trends impacting trial site ecosystem.
Kate Woda, Senior Director of Partnerships with Sites, highlighted the summit's goal of helping all stakeholders be more successful in recruiting the right patients for the right trials at the right time. She stated that this summit is designed to benefit everyone involved in the clinical research process.
Partnerships with Sites will be followed by DPHARM: Disruptive Innovations to Modernize Clinical Research on September 16-17, also at the Loews Philadelphia Hotel. This two-day event will provide further insights and strategies for modernizing clinical research. To learn more about Partnerships with Sites and DPHARM, visit partnershipswithsites.com.
Valerie Bowling, Executive Director of Conference Forum, emphasized the urgency of this summit by stating that "the time is now" for sites to face the increasing burden of complex protocols and high demands for trials. The Partnerships with Sites Summit will provide essential insights and strategies for sites to rebuild and reorient their ecosystem towards success in patient enrollment.
The summit boasts a diverse representation of stakeholders who will engage in frank discussions on how to build an infrastructure that supports site success in patient recruitment and retention. Along with sites and CROs, leading pharmaceutical companies such as Merck, Biogen, Boehringer Ingelheim, Eli Lilly & Co, and Endo will also be presenting at the summit.
More on The PennZone
- 10 Warning Signs a Roof May Need Repair Before Major Damage Occurs
- $1B Target by 2027 Amid eSIM, Global Roaming Expansion; $57.6M Q1 Revenue and Market Uplisting, Advancing Toward IQSTEL, Inc. (Stock Symbol: IQST)
- LIB TH-50/TH-80 Benchtop Environmental Chamber Drives Global Demand
- Marc Soucy's Newest Music Series Approaches Its One Year Mark
- Fairmint Releases Whitepaper for Open Captable Protocol (OCP) to Advance On-Chain Equity Securities
Confirmed members of the speaking faculty include senior leadership from prominent organizations such as the Society of Clinical Research Sites, The Site Council, the Association for MultiSite Research Corp, and Tufts Center for the Study of Drug Development. They will cover a range of topics including key trends impacting the site ecosystem, collaborations between site networks and bridging technology gaps for more efficient clinical trial operations.
Some of the key topics that will be addressed at this summit include building systems and relationships focused on enrollment goals, addressing site burden through operational efficiency, establishing sustainable partnership infrastructure between sites, pharma and CROs, rebuilding trust through proactive involvement of sites in protocol feasibility assessment, bridging technology gaps to reduce burden on sites and key trends impacting trial site ecosystem.
Kate Woda, Senior Director of Partnerships with Sites, highlighted the summit's goal of helping all stakeholders be more successful in recruiting the right patients for the right trials at the right time. She stated that this summit is designed to benefit everyone involved in the clinical research process.
Partnerships with Sites will be followed by DPHARM: Disruptive Innovations to Modernize Clinical Research on September 16-17, also at the Loews Philadelphia Hotel. This two-day event will provide further insights and strategies for modernizing clinical research. To learn more about Partnerships with Sites and DPHARM, visit partnershipswithsites.com.
Filed Under: Business
0 Comments
Latest on The PennZone
- Cycurion Wins $33M Cybersecurity Contract for State Colleges, Also $6M from Transportation Agency: Cycurion, Inc. (Stock Symbol: CYCU) is Undervalued
- Novel 'We Won't Go Back' Published; Addresses Women's Issues
- Djigui Consortium: A New Era of US-Africa Partnership
- Call for Papers Deadline Approaching – Don't Miss Your Shot to Speak at the OpenSSL Conference 2025!
- DICK'S Sporting Goods Reports Preliminary Results for First Quarter of 2025; Reports Comparable Sales Growth of 4.5%
- Simplified Marketing Announces ROI-Focused Webinar for B2B Teams Struggling to Justify Their Spend
- The ROS1ders Announces Recipients of 2024 ROS1+ Cancer Innovation Awards
- AUACOM Signs a Statement of Shared Interest with BMCC
- WWSG Announces Exclusive Speaking Partnership with Patrick McGee, Author of 'Apple in China'
- Celebrating Love with Unique Bridal Cocktail Favors
- Multi-Billion Dollar Drone Cleaning Market Addressed via New UAE Office, AI Drone and Quantum Computing Solutions in Varied Industries ZenaTech, Inc
- Spac Recovery Co. Files $590 Million Lawsuit Against Blackstone Products, Nomura , Franklin Square, Oaktree et al
- NBA Champion Lamar Odom Launches Anti-Addiction Meme Coin, Sparking Disruptive Innovation in Web3
- GormanSquared Unveils the Electronic Guardian Partner Program:Join the Revolution in Estate Security
- Plan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
- Tribeca Film Festival Official Podcast Selection Lead Features Hollywood Stars, Focuses On Ending Childhood Lead Poisoning In New York!
- Industrial Parts Fittings Champions the Revival of American Manufacturing
- "CEO Marathon: Spotlight Series"
- Braces in Reading Available from Exeter Smiles for One Transparent Price